Two days after the Senate Judiciary Committee passed a comprehensive immigration reform bill, House Minority Leader Nancy Pelosi (D-Calif.) promised that U.S. taxpayers would not bear the cost of healthcare coverage for undocumented immigrants who are on the path to citizenship.
“We said it in the Affordable Care Act, and we say it here again—that undocumented people will not have access to subsidies under the Affordable Care Act,” Pelosi said. “Any representation to the contrary is simply not true. It's stated very clearly in the Affordable Care Act. It is our position on the immigration bill: no access to subsidies in the Affordable Care Act,” she said. “Secondly, no access to Medicaid. No cost to the taxpayer—that has always been the Democratic position.”
Read the full story here: http://bit.ly/16SZnh9
Source: Modern Healthcare
Earlier reports had hinted that the coverage provisions under the Patient Protection and Affordable Care Act might be a sticking point as House members draft their own immigration-reform legislation. Not so, Pelosi said during her weekly news conference on Thursday, adding that undocumented immigrants would not have access to Medicaid. The California Democrat said the country must have comprehensive immigration form, and that legislation must protect the nation's borders, workers and taxpayers.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More